Theraclion S.A.

https://www.theraclion.com

Theraclion is a French company specializing in high-tech medical equipment using therapeutic ultrasound. Drawing on leading-edge technologies, Theraclion has designed and manufactured an innovative solution for echotherapy, the Echopulse®, allowing non-invasive tumor treatment through ultrasound-guided high-intensity focused ultrasound. Theraclion is ISO 13485 certified and has received the CE mark for non-invasive ablation of breast fibroadenomas and thyroid nodules. Based in Malakoff, near Paris, France Theraclion has brought together a team of 34 people, 50% of whom are dedicated to R&D and clinical trials. *

	Start	2004-08-05 established
	Industry	medical device
	Person	Caumartin, David (Theraclion 201608 CEO)

	Region	Paris
	Country	France
	Street	102 rue Etienne Dolet
	City	92240 Malakoff
	Tel	+33-1-5548-9070
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for ï¿½About Sectionï¿½: Theraclion S.A.. (8/18/16). "Press Release: Strong Interest of Investors in Theraclion – Capital increase Completed @ 100%. Total Amount Raised of €9,7M [Not for UK] 1,7 new shares issued at €5.98 per share". Malakoff.

		Record changed: 2019-06-09

Picture ConsulTech GmbH RnD Credit Germany 650x80px

More documents for Theraclion S.A.

[1] Theraclion S.A.. (8/18/16). "Press Release: Strong Interest of Investors in Theraclion – Capital increase Completed @ 100%. Total Amount Raised of €9,7M [Not for UK] 1,7 new shares issued at €5.98 per share". Malakoff....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]